T. Rowe Price Health Sciences Fund (PRHSX)

Access innovative companies in a dynamic industry.

Call 866-349-5897 to speak to an investment specialist about the
Health Sciences Fund.

Ticker Symbol:
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 06/30/2018
Volatility and Other Measures
as of 06/30/2018
Beta 1.18
Standard Deviation 15.53
Price/Earnings Ratio (Domestic) 22.2
Earnings Growth Rate (Domestic) 13.5
Turnover Rate 18.9
Median Market
$35,838.1 Million
Sector Diversification
as of 06/30/2018
% of Total Net Assets
Biotechnology 37.5%
Services 23.2%
Products & Devices 19.3%
Pharmaceuticals 11.4%
Life Sciences 8.0%
Miscellaneous 0.0%
10 Largest Holdings
Represents 34.75 % of Total Net Assets
View Holdings as of:
Alexion Pharmaceuticals
Becton, Dickinson & Company
Intuitive Surgical
SAGE Therapeutics
Thermo Fisher Scientific
UnitedHealth Group
Vertex Pharmaceuticals
As of 06/30/2018 the Health Sciences Fund had a total of 179 holdings.
See Glossary for additional details on all data elements.